Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Molecular Cancer|June 6, 2021
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myelomaChunyan Gu, Wang Wang, Xiaozhu Tang, et al.
European Radiology|January 16, 2016
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biologyElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Haematologica|November 28, 2015
Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myelomaNiels Weinhold, Desiree Kirn, Anja Seckinger, et al.
European Journal of Haematology|February 15, 2026
Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025Mimi Choon-Quinones, George Dennis Obeng, Benjamin Asiedu-Ayeh, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Oncotarget|December 31, 2015
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cellsSusanne Lub, Anke Maes, Ken Maes, et al.
Haematologica|March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myelomaElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Leukemia & Lymphoma|June 11, 2014
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescuePing Wu, Brian A Walker, Annemiek Broyl, et al.
Cancer Immunology Research|September 15, 2017
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine SecretionKim De Veirman, Nathan De Beule, Ken Maes, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Molecular Cancer|June 6, 2021
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myelomaChunyan Gu, Wang Wang, Xiaozhu Tang, et al.
European Radiology|January 16, 2016
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biologyElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Haematologica|November 28, 2015
Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myelomaNiels Weinhold, Desiree Kirn, Anja Seckinger, et al.
European Journal of Haematology|February 15, 2026
Increasing Trends of Minimal Residual Disease Measurement in Trials Focusing on Multiple Myeloma Treatment: A Systematic Analysis of Clinical Research Design From 2014 to 2025Mimi Choon-Quinones, George Dennis Obeng, Benjamin Asiedu-Ayeh, et al.
Frontiers in Oncology|November 11, 2021
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the PrognosisCyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, et al.
Oncotarget|December 31, 2015
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cellsSusanne Lub, Anke Maes, Ken Maes, et al.
Haematologica|March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myelomaElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Leukemia & Lymphoma|June 11, 2014
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescuePing Wu, Brian A Walker, Annemiek Broyl, et al.
Cancer Immunology Research|September 15, 2017
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine SecretionKim De Veirman, Nathan De Beule, Ken Maes, et al.
Pageof 19